The small interfering RNA (siRNA)-mediated suppression of AE1 has inhibited the growth of gastric carcinoma in in vitro [3, 5, 8, 9] and in vivo studies [12], indicating its potential as a target for cancer therapy. This evidence concerns the gene SLC4A1 and gastric carcinoma.